Brief: Xspray Pharma To Get About SEK 135 Mln From Rights Issue
Dec 2 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* STRONG INTEREST IN XSPRAY PHARMA RIGHTS ISSUE -
PRELIMINARY
OUTCOME
* COMPANY HAD RESOLVED ON A RIGHTS ISSUE OF 3,376,226 SHARES
* TO RECEIVE APPROXIMATELY SEK 135 MILLION FROM RIGHTS ISSUE
Source text: ID:nMFNc6TnK3
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003